Cellceutix Corporation stock (CTIX) had impressive run from low 80 cents to over $2.40 in a month+. CTIX stock is in overbought condition (that’s obvious) but most important that it is heavily overvalued. Take a brief look at company’s products and its financials: 1. Cellceutix’s psoriasis compound, Prurisol™ Prurisol is a small molecule, acting on […]